ArticleMedicina (Kaunas, Lithuania)2026

GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study.

Musa Salmanoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.